BioSpace News Archive

Business

Terso Solutions Partners With ImplantBase to Automate Inventory Management and Improve Performance for Orthopedic and Spine Companies Using RFID Technology

Terso Solutions and ImplantBase have partnered to deliver an end-to-end, automated inventory management solution using Terso’s RAIN RFID Mobile Case.

January 16, 2018
·
3 min read
Drug Development

Sidoris Biomedical, an AMI subsidiary, Announces Successful Anastomosis Achieved Using Novel Bioresorbable Circular Staples in Ongoing Animal Studies

Sidoris Biomedical has announced that successful anastomosis was achieved using internal circular staples fabricated with BioDG’s proprietary bioresorbable metal in ongoing animal studies.

January 16, 2018
·
2 min read
BioCapital

Intrexon Corp. Announces Proposed Public Offering of Common Stock

The offering is subject to market and other conditions and there can be no assurances as to whether or when the offering may be completed, or as to the size or terms of the offering.

January 16, 2018
·
3 min read
Business

START & Sarah Cannon Partner to Advance Therapies for Patients with Cancer

Partnering on the scientific and operational elements of drug development will lead to even greater efficiencies in the enrollment, quality and excellence of their clinical research programs.

January 16, 2018
·
4 min read
Genetown

Hologic Announces Pricing of Offering of $1B of Senior Notes

The additional 2025 notes will be issued under the indenture dated October 10, 2017 that governs Hologic’s 4.375% senior notes due 2025 dated October 10, 2017.

January 16, 2018
·
3 min read
Drug Development

Aspyrian Therapeutics Announces Successful Advances in RM-1929 Clinical Development in Recurrent Head and Neck Cancer, Including Fast Track Designation Granted by the FDA

RM-1929 is currently being tested in an ongoing Phase 2 study in recurrent Head and Neck cancer.

January 16, 2018
·
8 min read
ESSA Expects 180-Day Extension to Regain Compliance With the Nasdaq Bid Price Rule

The Company expects the Nasdaq Notice to indicate that while the Company has not regained compliance with the Bid Price Rule, it will be eligible for an additional 180-day grace period, until approximately July 16, 2018.

January 16, 2018
·
5 min read
Policy

Sandoz Regulatory Submission for Proposed Biosimilar Adalimumab Accepted by FDA

Sandoz announced today that the FDA has accepted its BLA for proposed biosimilar adalimumab to the reference medicine, Humira.

January 16, 2018
·
7 min read
APRINOIA Therapeutics Closes $11M Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer’s Disease

The proceeds of the funding will be used to finance preclinical and clinical development for APRINOIA’s imaging diagnostic and therapeutic pipelines.

January 16, 2018
·
4 min read
Drug Development

Novartis’ Cosentyx Beats Johnson & Johnson’s Stelara in Head-to-Head Trial

The safety profile of Cosentyx was in line with the known safety profile.

January 16, 2018
·
17 min read